Stock Events

Stock Events

Estrella Immunopharma 

$0.081200
5
+$0.00+4.77% Friday 19:41

Statistics

Day High
0.0775
Day Low
0.075
52W High
0.0812
52W Low
0.075
Volume
20
Avg. Volume
-
Mkt Cap
3.53M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2DecExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.19
-0.14
-0.1
-0.05
Expected EPS
-0.08
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
2025
0Revenue
-13.06MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ESLAW. It's not an investment recommendation.
Apple
2
AAPL
Microsoft
2
MSFT
Realty Income
2
O
Tesla
2
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Show more...
CEO
Cheng Liu
Employees
3
Country
United States
ISIN
US2975841121

Listings

XNAS
US
ESLAW
BOATS
BOATS
ESLA.BOATS
XNAS
US
ESLA

0 Comments

Share your thoughts

FAQ

What is Estrella Immunopharma stock price today?▼
The current price of ESLAW is $0.08 USD — it has increased by +4.77% in the past 24 hours. Watch Estrella Immunopharma stock price performance more closely on the chart.
What is Estrella Immunopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Estrella Immunopharma stocks are traded under the ticker ESLAW.
What is Estrella Immunopharma market cap?▼
Today Estrella Immunopharma has the market capitalization of 3.53M
When is the next Estrella Immunopharma earnings date?▼
Estrella Immunopharma is going to release the next earnings report on December 02, 2026.
What is Estrella Immunopharma revenue for the last year?▼
Estrella Immunopharma revenue for the last year amounts to 0 USD.
What is Estrella Immunopharma net income for the last year?▼
ESLAW net income for the last year is -13.06M USD.
How many employees does Estrella Immunopharma have?▼
As of September 04, 2026, the company has 3 employees.
In which sector is Estrella Immunopharma located?▼
Estrella Immunopharma operates in the Health & Wellness sector.
When did Estrella Immunopharma complete a stock split?▼
Estrella Immunopharma has not had any recent stock splits.
Where is Estrella Immunopharma headquartered?▼
Estrella Immunopharma is headquartered in EMERYVILLE, United States.